Sven Jarius
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 203 publications
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.
Journal: Neurology
Published: July 02, 2026
Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 23, 2026
HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum Disorders.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 16, 2026
An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion types.
Journal: Journal of neurology
Published: January 15, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.
Journal: Neurological research and practice
Published: December 19, 2025
Copine-5-IgG-related autoimmune encephalitis: a novel paraneoplastic neurological syndrome with a strong melanoma association.
Journal: Journal of neuroinflammation
Published: December 14, 2025
Impaired suppressive effect of FoxP3 regulatory T cells on B cells in multiple sclerosis.
Journal: Journal of neuroinflammation
Published: November 05, 2025
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS).
Journal: European journal of neurology
Published: August 12, 2025
Cognitive function in patients with myelin oligodendrocyte glycoprotein antibody-associated disease.
Cognitive function in patients with myelin oligodendrocyte glycoprotein antibody-associated disease.
Journal: Journal of neurology
Published: July 02, 2025
ITPR1 autoantibody-associated autoimmunity as a cause of newly emerging cognitive decline mimicking Alzheimer's disease: Case report and brief review of the literature.
Journal: Journal of neuroimmunology
Published: June 30, 2025
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.
Journal: EBioMedicine
Published: May 30, 2025
Retrospective In Silico Analysis of Routine Laboratory Data Supports a Specific Association of Epstein-Barr Virus and Multiple Sclerosis.
Journal: European journal of neurology
Published: February 21, 2025
Last Updated: 09/26/2026